https://www.selleckchem.com/products/biocytin.html
Off-label medication usage (OLMU) is prevalent in the treatment of various diseases, including female reproductive health issues (FRHIs). However, there is a paucity of literature on the perspective of health professionals on this subject. The purpose of the current study was to assess gynecologists/obstetricians' knowledge, attitude and practice toward OLMU in the treatment of FRHIs. The current cross-sectional study was conducted in September and October 2021, at five tertiary care hospitals (two public and three private sector), dif
Like
Comment
Share
